Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Correction: Population Pharmacokinetic-Pharmacodynamic Relationships of Sarilumab Using Disease Activity Score 28‑Joint C‑Reactive Protein and Absolute Neutrophil Counts in Patients with Rheumatoid Arthritis.
Journal: Clinical pharmacokinetics
Published: July 10, 2026
Summary of Research: Immunogenicity of Dupilumab in Adult and Pediatric Patients with Atopic Dermatitis.
Journal: Dermatology and therapy
Published: March 02, 2026
Drug-drug interaction assessments of clinical transporter inhibition: Learnings from the Transporter Working Group of the International Consortium for Innovation and Quality in Pharmaceutical Development.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: November 14, 2025
Modeling, Simulation, and Extrapolation to Optimize Pediatric Development Plan: Sarilumab Polyarticular-Course juvenile arthritis Application.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: July 11, 2025
Population Pharmacokinetics of Dupilumab in Adults, Adolescents, and Children With Eosinophilic Esophagitis.
Journal: Clinical pharmacology and therapeutics
Published: June 23, 2025
Opportunities for AI-based Model-informed Drug Development: A Comparative Analysis of NONMEM and AI-based Models for Population Pharmacokinetic Prediction.
Journal: The AAPS journal
Published: March 27, 2025
eIF3: a critical player in mRNA recruitment to the ribosome with emerging roles across translation.
Journal: Biochemical Society transactions
Published: March 25, 2025
Evaluating the Impact of AI-Based Model-Informed Drug Development (MIDD): A Comparative Review.
Journal: The AAPS journal
Published: January 24, 2025
Sarilumab in Polyarticular-Course Juvenile Idiopathic Arthritis: Dose-Finding and 1-Year Analysis of a Phase 2b, Open-Label, Multicenter Study.
Journal: Arthritis care & research
Published: January 22, 2025
Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling of Dupilumab on Pre-Bronchodilator Forced Expiratory Volume in 1 Second (FEV1) in Uncontrolled Moderate-To-Severe Asthma.
Journal: CPT: pharmacometrics & systems pharmacology
Published: December 19, 2024
Population Pharmacokinetics and Exposure-Response Analyses of Sarilumab in Patients with Polymyalgia Rheumatica.
Journal: Journal of clinical pharmacology
Published: December 10, 2024
Atuzabrutinib Topical Gel Does Not Improve Disease Activity in Patients with Mild-to-Moderate Atopic Dermatitis: Findings from a Phase 2A Trial.
Journal: The Journal of investigative dermatology
Published: September 10, 2024
Last Updated: 09/26/2026